Search

Abnormalities in the tricuspid valve have a lower incidence than defects in the rest of the heart valves and may be due to primary or secondary causes. Recently, its pathophysiology and importance in morbidity and mortality due to cardiac causes have been widely studied. Open tricuspid valve surgery has a high rate of morbidity and mortality, and even more so when it comes to reoperation. For this reason, it is important to carry out these procedures endovascularly via a transcatheter catheter and some cases of exacerbations by this method have recently been published throughout the world, by means of percutaneous valve-in-valve implantation in the tricuspid position. We present the first reported case of this procedure in Colombia in a pediatric patient, whose procedure was uneventful and a significant improvement in valve function was impaired, as an initial step to continue developing the technique and performing the procedure in this country. [ABSTRACT FROM AUTHOR]

Background: Ebstein's anomaly is a rare complex congenital heart disease, first described in 1866 by physician Wilhelm Ebstein, characterized by anatomical and functional malformations of the tricuspid valve and the right ventricle because of inadequate delaminization of the tricuspid valve tissue. By presenting a clinical case and reviewing the literature, we analyzed the approach of an adult patient with Ebstein anomaly with ventricular preexcitation. Clinical case: We describe the case of a 34-year-old male patient, with a clinical history of palpitations and dyspnea, and his paraclinics documented Ebstein type B anomaly associated with patent foramen oval and paroxysmal supraventricular tachycardia, Successful radiofrequency ablation was performed and tricuspid valvuloplasty was proposed. Conclusion: It is concluded that Ebstein's anomaly is complex with clinical, morphological and physiopathological heterogeneous spectrum. Manifested from severe symptomatic forms in the neonatal period to asymptomatic or minimally symptomatic ones detected incidentally. Its diagnosis is based on clinical suspicion and confirmed by echocardiography or imaging studies. The therapeutic strategy may be based on medical management in its mild asymptomatic forms up to surgical interventions that include tricuspid valvuloplasty, palliative surgery, valve replacement or cardiac transplantation. [ABSTRACT FROM AUTHOR]

BACKGROUND: The right side infectious endocarditis represents 5% of all endocarditis, usually associated with different risk factors. CLINICAL CASE: A 56-year-old male patient who presented tricuspid valve endocarditis without having risk factors with the typical clinical picture, besides presenting as a complication a septic pulmonary embolism due to the endocardial vegetation detachment. CONCLUSIONS: Within the clinical picture, a systolic murmur of tricuspid regurgitation with the peculiarity of being uniform, holosystolic and increasing with inspiration can be identified. In addition, the characteristic symptoms of the tricuspid syndrome, which are given by anemia, hematuria and low respiratory infection, can be found. Duke criteria were used to perform the diagnosis, which complied with our patient, although a positive blood culture was not evidenced, which may be associated with different factors. The treatment must be initiated empirically, but the antibiogram report should always be available. [ABSTRACT FROM AUTHOR]

This is a case report of a 43-year-old Caucasian male with end-stage renal disease being treated with hemodialysis and infective endocarditis in the aortic and tricuspid valves. The clinical presentation was dominated by neurologic impairment with cerebral embolism and hemorrhagic components. A thoracoabdominal computerized tomography scan revealed septic pulmonary embolus. The patient underwent empirical antibiotherapy with ceftriaxone, gentamicin and vancomycin, and the therapy was changed to flucloxacilin and gentamicin after the isolation of S. aureus in blood cultures. The multidisciplinary team determined that the patient should undergo valve replacement after the stabilization of the intracranial hemorrhage; however, on the 8th day of hospitalization, the patient entered cardiac arrest due to a massive septic pulmonary embolism and died. Despite the risk of aggravation of the hemorrhagic cerebral lesion, early surgical intervention should be considered in high-risk patients. [ABSTRACT FROM AUTHOR]

Tricuspid valve endocarditis is rare and usually associated with the use of intravenous drugs or intravascular dispositives. Although it is recognized that infection of the tricuspid valve does occur in healthy people with no other known risk factors, then is thought to be extremely rare. Uncomplicated tricuspid valve endocarditis can be successfully medical treated in 80% of patients, in the remaining 20%, with very large vegetation such as in the presented case, surgical treatment is required. We present the case of a previously healthy young woman who arrived to the intensive care unit with sepsis, nodular lung infiltrates and tricuspid endocarditis, the blood cultures were positive for Staphylococcus aureus. The patient was treated with linezolid and the infected tricuspid valve was replaced with a biological heart valve, the patient recovered uneventfully. [ABSTRACT FROM AUTHOR]

Introduction. The Ebstein anomaly is less than 1% of all congenital heart defects. It consists in the displacement of an anomalous tricuspid valve into the right ventricle. Report: Male patient, 8 years old from Trujillo, with a diagnosis of Ebstein disease at 1 month of age, admitted for emergency with cyanosis and chest pain presenting Interpretation: The Ebstein anomaly is less than 1% of all congenital heart defects. It consists in the down displacement of an anomalous tricuspid valve into the right ventricle. [ABSTRACT FROM AUTHOR]